Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL

Source: Smarter. Stronger. Together. Progressing Toward Optimal CLL Care Through Healthcare Professional and Patient Education

In this interactive virtual presentation, expert faculty discuss best practices in identifying and managing key adverse events commonly associated with BCL-2 and PI3K inhibitors in patients with CLL.